<?xml version="1.0" encoding="UTF-8"?>
<p>No serious adverse events were associated with convalescent plasma treatment.
 <xref rid="trf15797-bib-0004" ref-type="ref">4</xref>, 
 <xref rid="trf15797-bib-0005" ref-type="ref">5</xref>, 
 <xref rid="trf15797-bib-0031" ref-type="ref">31</xref> The most commonly reported mild adverse event was a brief “chill” reaction with a transient hyperpyrexia after the convalescent plasma transfusion. Few patients develop transfusion‐related adverse events such as phlebitis, generalized jaundice, or anaphylaxis.
 <xref rid="trf15797-bib-0024" ref-type="ref">24</xref> A case report raised an association between transfusion‐related acute lung injury and convalescent plasma.
 <xref rid="trf15797-bib-0032" ref-type="ref">32</xref>
</p>
